Jounce Therapeutics (JNCE) Reaches $16.46 After 5.00% Down Move; Garmin Limited Switzerland (GRMN) Sellers Increased By 2.4% Their Shorts

October 3, 2017 - By Michael Collier

Garmin Limited Switzerland (NASDAQ:GRMN) had an increase of 2.4% in short interest. GRMN’s SI was 16.37M shares in October as released by FINRA. Its up 2.4% from 15.99M shares previously. With 864,900 avg volume, 19 days are for Garmin Limited Switzerland (NASDAQ:GRMN)’s short sellers to cover GRMN’s short positions. The SI to Garmin Limited Switzerland’s float is 18.59%. About 197,136 shares traded. Garmin Ltd. (NASDAQ:GRMN) has risen 28.63% since October 3, 2016 and is uptrending. It has outperformed by 11.93% the S&P500.

The stock of Jounce Therapeutics Inc (NASDAQ:JNCE) is a huge mover today! About 105,773 shares traded. Jounce Therapeutics Inc (NASDAQ:JNCE) has 0.00% since October 3, 2016 and is . It has underperformed by 16.70% the S&P500.The move comes after 7 months negative chart setup for the $529.92M company. It was reported on Oct, 3 by Barchart.com. We have $15.64 PT which if reached, will make NASDAQ:JNCE worth $26.50M less.

Analysts await Jounce Therapeutics Inc (NASDAQ:JNCE) to report earnings on November, 8. After $-0.11 actual earnings per share reported by Jounce Therapeutics Inc for the previous quarter, Wall Street now forecasts 127.27% negative EPS growth.

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The company has market cap of $529.92 million. The Firm is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. It has a 7550.46 P/E ratio. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient.

Investors sentiment decreased to 1.12 in Q2 2017. Its down 0.42, from 1.54 in 2017Q1. It turned negative, as 39 investors sold Garmin Ltd. shares while 106 reduced holdings. 41 funds opened positions while 121 raised stakes. 71.31 million shares or 4.03% less from 74.31 million shares in 2017Q1 were reported. 34,590 were reported by Diversified Invest Strategies Limited Liability Corp. Norinchukin Retail Bank The holds 13,162 shares or 0.01% of its portfolio. Twin Cap Mgmt stated it has 0.13% of its portfolio in Garmin Ltd. (NASDAQ:GRMN). Goldman Sachs Grp stated it has 0.02% in Garmin Ltd. (NASDAQ:GRMN). Utah Retirement Sys stated it has 0.03% of its portfolio in Garmin Ltd. (NASDAQ:GRMN). Moreover, Prelude Cap Mgmt Lc has 0% invested in Garmin Ltd. (NASDAQ:GRMN) for 496 shares. Kbc Gp Nv holds 0.01% or 17,249 shares in its portfolio. Ingalls And Snyder Ltd Liability owns 13,450 shares. Millennium Mgmt Ltd Limited Liability Company reported 0% in Garmin Ltd. (NASDAQ:GRMN). Legal And General Public Limited invested 0.03% in Garmin Ltd. (NASDAQ:GRMN). Voya Investment Management Ltd Co holds 0.02% of its portfolio in Garmin Ltd. (NASDAQ:GRMN) for 185,516 shares. Fred Alger Mgmt accumulated 20,547 shares. Amer Research And Mngmt has 100 shares for 0% of their portfolio. State Of Tennessee Treasury Department reported 31,380 shares stake. Atwood And Palmer has invested 0.01% in Garmin Ltd. (NASDAQ:GRMN).

Since May 26, 2017, it had 0 insider buys, and 2 sales for $15.67 million activity. Shares for $5.25M were sold by BURRELL JONATHAN.

Garmin Ltd. and subsidiaries offer global positioning system (GPS) navigation and wireless devices and applications. The company has market cap of $10.76 billion. The Firm operates through five divisions. It has a 15.32 P/E ratio. It offers a range of auto navigation products, as well as a range of products and applications designed for the mobile GPS market.